Faulty Impella Controllers; Redo TAVR OK’d; Breath Tests for MI Patients?



(MedPage Today) — Abiomed is taking certain Impella Controllers off the market due to failing circuitry. One related death has already been reported, the FDA alerted.
Medtronic announced FDA approval of a redo transcatheter aortic valve replacement…



Source link : https://www.medpagetoday.com/cardiology/generalcardiology/117260

Author :

Publish date : 2025-09-02 15:15:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version